PDCD1 and cancer: However, since PP inhibits mitochondria, the WNT pathway and cancer cell viability at concentrations that are orders of magnitude lower than the noted IC50 for PD-1/PDL-1 inhibition, this immunoactive mechanism is likely not a relevant MOA for PP.